97 related articles for article (PubMed ID: 7496733)
1. PCNA defined proliferative activity of epithelial tumor cells in adenomas of the colon.
Bielicki D; Markiewski M; Wielondek M; Chosia M; Domagała W
Pol J Pathol; 1995; 46(3):151-4. PubMed ID: 7496733
[TBL] [Abstract][Full Text] [Related]
2. [Possible prognostic role of PCNA in colonic adenomas].
Tranchina MG; Puzzo L
Pathologica; 1993; 85(1100):679-85. PubMed ID: 7909595
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity in colonic adenomas as a predictor of metachronous adenomas as assessed by proliferating cell nuclear antigen immunohistochemistry.
Paspatis GA; Karamanolis DG; Vasilakaki T; Zizi A; Xourgias V; Elemenoglou I; Hadziyannis SJ
Am J Gastroenterol; 1995 Apr; 90(4):597-602. PubMed ID: 7717318
[TBL] [Abstract][Full Text] [Related]
4. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
5. [The assessment of colonic polyps found via colonoscopy].
Linares Santiago E; Gómez Parra M; Pellicer Bautista F; Romero Castro R; Caunedo Alvarez A; Mendoza Olivares FJ; Catalán Ramírez JM; Herrerías Esteban JM; Rivera Hueto F; Herrerías Gutiérrez JM
Gastroenterol Hepatol; 1999; 22(6):273-8. PubMed ID: 10410446
[TBL] [Abstract][Full Text] [Related]
6. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
Risio M; Candelaresi G; Rossini FP
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
[TBL] [Abstract][Full Text] [Related]
7. Cell turnover of serrated adenomas.
Ladas SD; Kitsanta P; Triantafyllou K; Tzathas C; Spiliadi C; Raptis SA
J Pathol; 2005 May; 206(1):62-7. PubMed ID: 15751053
[TBL] [Abstract][Full Text] [Related]
8. Association of APC gene mutations and histological characteristics of colorectal adenomas.
De Benedetti L; Sciallero S; Gismondi V; James R; Bafico A; Biticchi R; Masetti E; Bonelli L; Heouaine A; Picasso M
Cancer Res; 1994 Jul; 54(13):3553-6. PubMed ID: 8012980
[TBL] [Abstract][Full Text] [Related]
9. [Tissue expression of carbohydrate antigen 19-9 (CA 19-9) in adenomatous lesions of the colorectum].
Tucci GF; Grande M; Stroppa I; Federico F; Farinon AM
Chir Ital; 1999; 51(2):165-72. PubMed ID: 10514933
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
Darmon E; Cleary KR; Wargovich MJ
Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of different biomarkers (DNA content, PCNA, karyotype) in colorectal adenomas.
Lavezzi AM; Ottaviani G; De Ruberto F; Fichera G; Matturri L
Anticancer Res; 2002; 22(4):2077-81. PubMed ID: 12174886
[TBL] [Abstract][Full Text] [Related]
13. Histological assessment of colorectal adenomas by size. Are polyps less than 10 mm in size clinically important?
Aldridge AJ; Simson JN
Eur J Surg; 2001 Oct; 167(10):777-81. PubMed ID: 11775731
[TBL] [Abstract][Full Text] [Related]
14. Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen?
Holt PR; Moss SF; Kapetanakis AM; Petrotos A; Wang S
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):131-5. PubMed ID: 9037564
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
16. Medium-large polyps of the colon: a contribution for their clinical profile and a proper surveillance.
Grassi A; Casale V; Fracasso P; Lapenta R; Stigliano V; Giannarelli D; Bigotti G; Crespi M
J Exp Clin Cancer Res; 1997 Sep; 16(3):313-9. PubMed ID: 9387907
[TBL] [Abstract][Full Text] [Related]
17. Growth kinetics of colorectal adenoma-carcinoma sequence: an immunohistochemical study of proliferating cell nuclear antigen expression.
Yang HB; Hsu PI; Chan SH; Lee JC; Shin JS; Chow NH
Hum Pathol; 1996 Oct; 27(10):1071-6. PubMed ID: 8892593
[TBL] [Abstract][Full Text] [Related]
18. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
[TBL] [Abstract][Full Text] [Related]
19. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
[TBL] [Abstract][Full Text] [Related]
20. Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA.
Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Miwa A
Hepatogastroenterology; 1999; 46(27):1959-62. PubMed ID: 10430377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
